- Home
- INHD vs LGVN Comparison
INHD vs LGVN Comparison
Compare INHD & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INHD | LGVN |
|---|---|---|
| Founded | 2019 | 2014 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0M | 12.2M |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | INHD | LGVN |
|---|---|---|
| Price | $1.41 | $0.56 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.50 |
| AVG Volume (30 Days) | ★ 806.6K | 300.8K |
| Earning Date | 02-13-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,846,250.00 | $1,437,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.06 | $0.49 |
| 52 Week High | $474.72 | $1.92 |
Technical Indicators
Market Signals| Indicator | INHD | LGVN |
|---|---|---|
| Relative Strength Index (RSI) | 61.29 | 44.07 |
| Support Level | $1.29 | $0.52 |
| Resistance Level | $1.56 | $0.60 |
| Average True Range (ATR) | 0.18 | 0.04 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 58.72 | 42.57 |
Price Performance
Historical ComparisonAbout INHD Inno Holdings Inc.
Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.